Breast Neoplasms: all 12,815 studies

Page 127 of 129. Open to participants first (2,920), then studies with results posted, then the rest; newest registration first within each.

• Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous ChemotherapyTerminatedNCT00006121Phase 2
• Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast CancerStatus unknownNCT00006120Phase 2
• Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00006108Phase 1/2
• Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00006104Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerTerminatedNCT00006032Phase 2
• Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast CancerStatus unknownNCT00006030Phase 3
• LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNCT00006007Phase 2
• Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast CancerTerminatedNCT00005993Phase 1
• Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerCompletedNCT00005991Phase 2
• S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast CancerTerminatedNCT00005983Phase 3
• Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerCompletedNCT00005980Phase 2
• S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast CancerCompletedNCT00005975Phase 3
• Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerCompletedNCT00005970Phase 3
• Docetaxel and Carboplatin in Treating Women With Metastatic Breast CancerCompletedNCT00005963Phase 2
• Biological Therapy in Treating Patients With Advanced CancerCompletedNCT00005956Not applicable
• Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast CancerCompletedNCT00005886Phase 1
• Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00005873Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian CancerCompletedNCT00005858Phase 1
• SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast CancerCompletedNCT00005822Phase 1
• Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast CancerStatus unknownNCT00005821Phase 2
• Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast CancerCompletedNCT00005817Phase 2
• Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian CancerCompletedNCT00005807Phase 1
• Doxorubicin and Docetaxel in Treating Women With Stage III Breast CancerCompletedNCT00005800Phase 2
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast CancerCompletedNCT00005798Phase 2
• Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced CancerTerminatedNCT00005655Phase 1
• Paclitaxel and Capecitabine in Treating Women With Metastatic Breast CancerCompletedNCT00005649Phase 2
• Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2CompletedNCT00005635Phase 2
• Management of Metastatic Breast Cancer in Frail PatientsWithdrawnNCT00005614Phase 2
• Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast CancerTerminatedNCT00005608Phase 2
• Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast CancerCompletedNCT00005605
• Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast CancerStatus unknownNCT00005600Not applicable
• Radiation Therapy After Surgery in Treating Women With Early Stage Breast CancerCompletedNCT00005588Phase 3
• Radiation Therapy After Surgery in Treating Women With Early Stage Breast CancerCompletedNCT00005587Phase 3
• Combination Chemotherapy in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00005581Phase 3
• Prospective Study of Health in Runners and WalkersCompletedNCT00005494
• Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00005079Phase 3
• Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast CancerStatus unknownNCT00005058Not applicable
• Temozolomide in Treating Women With Advanced Breast CancerStatus unknownNCT00005054Phase 2
• Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV CancerCompletedNCT00005023Phase 1
• Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2TerminatedNCT00004935Phase 3
• Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast CancerCompletedNCT00004925Phase 1/2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerCompletedNCT00004906Phase 2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerCompletedNCT00004900Phase 2
• Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast CancerCompletedNCT00004893Phase 2
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00004604Phase 1
• Susceptibility to Breast CancerCompletedNCT00004565
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaTerminatedNCT00004261Phase 1
• Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00004237Phase 2
• Liposomal Daunorubicin in Treating Patients With Metastatic Breast CancerStatus unknownNCT00004207Phase 1
• Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast CancerCompletedNCT00004205Phase 3
• Irinotecan in Treating Patients With Metastatic or Recurrent Breast CancerCompletedNCT00004182Phase 2
• Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast CancerCompletedNCT00004175Phase 2
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerCompletedNCT00004174Phase 1
• Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerCompletedNCT00004172Phase 2
• Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsCompletedNCT00004157Phase 2
• Vaccine Therapy in Treating Patients With Breast CancerCompletedNCT00004156Phase 1
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesCompletedNCT00004125Phase 3
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00004095Phase 1
• Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast CancerCompletedNCT00004085Phase 1/2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2CompletedNCT00004067Phase 3
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
• Chemotherapy in Treating Women With Metastatic Breast CancerCompletedNCT00004046Phase 2
• Gene Therapy Plus Chemotherapy in Treating Patients With Breast CancerCompletedNCT00004038Phase 1
• Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast CancerCompletedNCT00004013Phase 2
• Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2CompletedNCT00003992Phase 2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast CancerCompletedNCT00003972Phase 3
• Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerCompletedNCT00003953Phase 2
• Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerCompletedNCT00003927Phase 1
• Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast CancerStatus unknownNCT00003920Phase 1
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenCompletedNCT00003906Phase 3
• Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone InvolvementCompletedNCT00003902Phase 1/2
• Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast CancerCompletedNCT00003893Phase 3
• Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
• Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast CancerCompletedNCT00003877Phase 1/2
• Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast CancerCompletedNCT00003855Phase 3
• Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast CancerCompletedNCT00003854Phase 3
• Irofulven in Treating Patients With Metastatic Breast CancerCompletedNCT00003796Phase 2
• Women's Healthy Eating and Living StudyCompletedNCT00003787
• Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast CancerCompletedNCT00003771Phase 3
• Vaccine Therapy in Treating Patients With Metastatic Breast CancerCompletedNCT00003761Phase 1
• Bexarotene in Treating Patients With Metastatic Breast CancerCompletedNCT00003752Phase 2
• MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast CancerCompletedNCT00003736Not applicable
• Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast CancerCompletedNCT00003730Not applicable
• Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00003690Phase 1
• Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast CancerStatus unknownNCT00003680Phase 3
• Combination Chemotherapy in Treating Women With Breast CancerStatus unknownNCT00003679Phase 3
• Tamoxifen in Treating Women With Breast CancerStatus unknownNCT00003678Phase 3
• Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate CancerCompletedNCT00003674Phase 3
• Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast CancerTerminatedNCT00003654Not applicable
• Vaccine Therapy in Treating Women With Metastatic Breast CancerCompletedNCT00003638Phase 3
• Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00003612Phase 2
• Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00003577Phase 3
• Docetaxel in Treating Patients With Solid TumorsCompletedNCT00003565Phase 2
• Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and PaclitaxelCompletedNCT00003540Phase 2
• Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00003539Phase 2
• Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast CancerWithdrawnNCT00003536Phase 2
• Combination Chemotherapy in Treating Women With Breast CancerCompletedNCT00003519Phase 3
• Antineoplaston Therapy in Treating Women With Advanced Breast CancerWithdrawnNCT00003455Phase 2
• Antineoplaston Therapy in Treating Women With Stage IV Breast CancerTerminatedNCT00003454Phase 2

← Breast Neoplasms overview